| Fri, 7 Aug 2026 | Andreessen Marc L | 10 percent owner | P-Purchase | 1,100,000 | $19.8M |
| Fri, 7 Aug 2026 | ORBIMED ADVISORS LLC | director, 10 percent owner | P-Purchase | 1,666,667 | $30M |
| Fri, 7 Aug 2026 | ORBIMED ADVISORS LLC | director, 10 percent owner | C-Conversion | 9,132,420 | — |
| Fri, 7 Aug 2026 | Chimovits Erez | director, 10 percent owner | P-Purchase | 273,333 | $4.92M |
| Fri, 7 Aug 2026 | Chimovits Erez | director, 10 percent owner | P-Purchase | 1,666,667 | $30M |
| Fri, 7 Aug 2026 | Chimovits Erez | director, 10 percent owner | C-Conversion | 9,132,420 | — |
| Fri, 7 Aug 2026 | AH Bio Fund IV, L.P. | 10 percent owner | P-Purchase | 1,100,000 | $19.8M |
| Fri, 7 Aug 2026 | AH Bio Fund IV, L.P. | 10 percent owner | C-Conversion | 9,132,420 | — |
| Fri, 7 Aug 2026 | OrbiMed Genesis GP LLC | director, 10 percent owner | P-Purchase | 1,666,667 | $30M |
| Fri, 7 Aug 2026 | OrbiMed Genesis GP LLC | director, 10 percent owner | P-Purchase | 273,333 | $4.92M |
| Fri, 7 Aug 2026 | OrbiMed Genesis GP LLC | director, 10 percent owner | C-Conversion | 9,132,420 | — |
| Fri, 7 Aug 2026 | Andreessen Marc L | 10 percent owner | C-Conversion | 9,132,420 | — |
| Fri, 7 Aug 2026 | ORBIMED ADVISORS LLC | director, 10 percent owner | P-Purchase | 273,333 | $4.92M |
| Fri, 7 Aug 2026 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10 percent owner | C-Conversion | 7,420,091 | — |
| Fri, 7 Aug 2026 | Forbion Growth Opportunities Fund III Cooperatief U.A. | 10 percent owner | C-Conversion | 7,990,867 | $0 |
| Fri, 7 Aug 2026 | Forbion Growth Opportunities Fund III Cooperatief U.A. | 10 percent owner | C-Conversion | 9,132,420 | $0 |
| Fri, 7 Aug 2026 | Lubner David Charles | director | P-Purchase | 55,555 | $999.99K |
| Fri, 7 Aug 2026 | Murdoch Travis | director, officer: CEO and President | P-Purchase | 83,333 | $1.5M |
| Fri, 7 Aug 2026 | Anderson Michele A. | officer: Chief Development Officer | P-Purchase | 1,111 | $20K |
| Fri, 7 Aug 2026 | Malek David I | director | P-Purchase | 4,166 | $74.99K |
| Fri, 7 Aug 2026 | Viehbacher Christopher | director | P-Purchase | 83,333 | $1.5M |
| Fri, 7 Aug 2026 | Rickey James Paul | officer: Chief Financial Officer | P-Purchase | 27,777 | $499.99K |
| Fri, 7 Aug 2026 | Forbion Growth Opportunities Fund III Cooperatief U.A. | 10 percent owner | P-Purchase | 1,920,000 | $34.56M |
| Fri, 7 Aug 2026 | Forbion Growth Opportunities Fund III Cooperatief U.A. | 10 percent owner | P-Purchase | 1,680,000 | $30.24M |